{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:20:35Z","timestamp":1791922835052,"version":"4.3.4"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.117010","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T21:10:50Z","timestamp":1719436250000},"page":"117010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Histone deacetylases and inhibitors in diabetes mellitus and its complications"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-4513","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6632","key":"10.1016\/j.biopha.2024.117010_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.biopha.2024.117010_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMra1402513","article-title":"The key role of epigenetics in human disease prevention and mitigation","volume":"378","author":"Feinberg","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.117010_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory[J]","volume":"15","author":"Kato","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","article-title":"Epigenetic modifications in cancer","volume":"81","author":"Kanwal","year":"2012","journal-title":"Clin. Genet"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13059-017-1250-y","article-title":"Genetic-epigenetic interactions in cis: a major focus in the post-GWAS era","volume":"18","author":"Do","year":"2017","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrg.2016.138","article-title":"From profiles to function in epigenomics","volume":"18","author":"Stricker","year":"2017","journal-title":"Nat. Rev. Genet"},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117010_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109118","article-title":"IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2024.117010_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40842-019-0080-0","article-title":"Global epidemiology of prediabetes - present and future perspectives","volume":"5","author":"Hostalek","year":"2019","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"9833","key":"10.1016\/j.biopha.2024.117010_bib12","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrendo.2014.170","article-title":"Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications","volume":"10","author":"Frier","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib14","first-page":"45","article-title":"Role of HDAC inhibitors in diabetes mellitus","volume":"68","author":"Makkar","year":"2020","journal-title":"Curr. Res Transl. Med"},{"issue":"10365","key":"10.1016\/j.biopha.2024.117010_bib15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117010_bib16","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061340","article-title":"The emerging role of HDACs: pathology and therapeutic targets in diabetes mellitus","volume":"10","author":"Dewanjee","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.117010_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3583067","article-title":"Metabolic and epigenetic action mechanisms of antidiabetic medicinal plants","volume":"2019","author":"Shanak","year":"2019","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.51.5.786","article-title":"Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis","volume":"51","author":"Allfrey","year":"1964","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrm3931","article-title":"50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond","volume":"16","author":"Verdin","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2024.117010_bib21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbapap.2016.06.007","article-title":"The world of protein acetylation","volume":"1864","author":"Drazic","year":"2016","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/mol.109.061333","article-title":"Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?","volume":"77","author":"Grayson","year":"2010","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41368-019-0053-2","article-title":"Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering","volume":"11","author":"Lawlor","year":"2019","journal-title":"Int J. Oral. Sci."},{"key":"10.1016\/j.biopha.2024.117010_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","article-title":"Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.117010_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8908751","article-title":"Emerging role of histone acetyltransferase in stem cells and cancer","volume":"2018","author":"Trisciuoglio","year":"2018","journal-title":"Stem Cells Int"},{"issue":"18","key":"10.1016\/j.biopha.2024.117010_bib27","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/nar\/25.18.3693","article-title":"Histone deacetylases, acetoin utilization proteins and acetylpolyamine amidohydrolases are members of an ancient protein superfamily","volume":"25","author":"Leipe","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/bjc.2016.36","article-title":"Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia","volume":"114","author":"Ceccacci","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117010_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2013.00036","article-title":"Sirtuins: from metabolic regulation to brain aging","volume":"5","author":"Duan","year":"2013","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenet."},{"issue":"37","key":"10.1016\/j.biopha.2024.117010_bib31","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.biopha.2024.117010_bib32","doi-asserted-by":"crossref","first-page":"E481","DOI":"10.1073\/pnas.1118403109","article-title":"Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development","volume":"109","author":"Ma","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.117010_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115111","article-title":"Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension","volume":"202","author":"Kee","year":"2022","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"LoPresti","year":"2020","journal-title":"Cells"},{"issue":"45","key":"10.1016\/j.biopha.2024.117010_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034577","article-title":"Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: a review","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2024.117010_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/0470862637.ch8","article-title":"HDAC7 regulates apoptosis in developing thymocytes","volume":"259","author":"Verdin","year":"2004","journal-title":"Novartis Found. Symp."},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCRESAHA.120.317723","article-title":"HDAC9: an inflammatory link in atherosclerosis","volume":"127","author":"Das","year":"2020","journal-title":"Circ. Res"},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib38","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210462","article-title":"Histone deacetylase 10, a potential epigenetic target for therapy","volume":"41","author":"Cheng","year":"2021","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib39","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1152\/physrev.00022.2011","article-title":"Sirtuin 1 and sirtuin 3: physiological modulators of metabolism","volume":"92","author":"Nogueiras","year":"2012","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib40","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1111\/jcmm.16411","article-title":"Helicobacter pylori inhibits autophagic flux and promotes its intracellular survival and colonization by down-regulating SIRT1","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"10","key":"10.1016\/j.biopha.2024.117010_bib41","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.7150\/thno.55330","article-title":"SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib42","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1002\/ijc.33118","article-title":"The role of SIRT2 in cancer: a novel therapeutic target","volume":"147","author":"Chen","year":"2020","journal-title":"Int J. Cancer"},{"issue":"29","key":"10.1016\/j.biopha.2024.117010_bib43","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1080\/10408398.2022.2070722","article-title":"Molecular and cellular regulatory roles of sirtuin protein","volume":"63","author":"Pande","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2024.117010_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fendo.2018.00783","article-title":"The roles of mitochondrial SIRT4 in cellular metabolism","volume":"9","author":"Min","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051101","article-title":"EX-527 prevents the progression of high-fat diet-induced hepatic steatosis and fibrosis by upregulating SIRT4 in zucker rats","volume":"9","author":"Kundu","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2009.02.026","article-title":"SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle","volume":"137","author":"Nakagawa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117010_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnins.2018.00032","article-title":"Metabolomics Based Identification of SIRT5 and Protein Kinase C Epsilon Regulated Pathways in Brain","volume":"12","author":"Koronowski","year":"2018","journal-title":"Front Neurosci."},{"issue":"16","key":"10.1016\/j.biopha.2024.117010_bib48","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.1519858113","article-title":"Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function","volume":"113","author":"Sadhukhan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12974-020-01906-1","article-title":"Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration","volume":"17","author":"Ferrara","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00125-015-3778-2","article-title":"Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells","volume":"59","author":"Xiong","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2024.117010_bib51","article-title":"HDAC11, an emerging therapeutic target for metabolic disorders","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","article-title":"Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders","volume":"66","author":"Konsoula","year":"2012","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"8","key":"10.1016\/j.biopha.2024.117010_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000784","article-title":"Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis","volume":"2","author":"North","year":"2007","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2024.117010_bib54","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1074\/jbc.M609554200","article-title":"Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1","volume":"282","author":"Tanno","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117010_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arr.2017.08.001","article-title":"Sirtuins, epigenetics and longevity","volume":"40","author":"W\u0105troba","year":"2017","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.biopha.2024.117010_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu Rev. Pathol."},{"issue":"10","key":"10.1016\/j.biopha.2024.117010_bib57","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1158\/1078-0432.CCR-04-2135","article-title":"Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes","volume":"11","author":"Kaminskas","year":"2005","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1634\/theoncologist.10-3-176","article-title":"FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension","volume":"10","author":"Kaminskas","year":"2005","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.20372","article-title":"Histone deacetylase inhibitors: understanding a new wave of anticancer agents","volume":"112","author":"Villar-Garea","year":"2004","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2024.117010_bib60","first-page":"721","article-title":"Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101","volume":"2","author":"Plumb","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib62","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2024.117010_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.703218","article-title":"The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis","volume":"9","author":"Visekruna","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib64","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib65","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/jm0303655","article-title":"Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors","volume":"47","author":"Lu","year":"2004","journal-title":"J. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biocel.2008.08.027","article-title":"Acetylation of non-histone proteins modulates cellular signalling at multiple levels","volume":"41","author":"Spange","year":"2009","journal-title":"Int J. Biochem Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117010_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113539","article-title":"Repression of transcriptional activity of Forkhead Box O1 by histone deacetylase inhibitors ameliorates hyperglycemia in type 2 diabetic rats","volume":"19","author":"Cho","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib68","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ. Res"},{"issue":"5-6","key":"10.1016\/j.biopha.2024.117010_bib69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2119\/molmed.2010.00152","article-title":"The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet \u03b2 cells in vivo and in vitro","volume":"17","author":"Lewis","year":"2011","journal-title":"Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib70","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1074\/mcp.O114.046565","article-title":"Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease","volume":"14","author":"Mathias","year":"2015","journal-title":"Mol. Cell Proteom."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/19382014.2015.1024405","article-title":"Structural similarities and differences between the human and the mouse pancreas","volume":"7","author":"Dolen\u0161ek","year":"2015","journal-title":"Islets"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib72","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1101\/gr.212720.116","article-title":"Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes","volume":"27","author":"Lawlor","year":"2017","journal-title":"Genome Res"},{"issue":"9","key":"10.1016\/j.biopha.2024.117010_bib73","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00125-012-2615-0","article-title":"Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children","volume":"55","author":"Lundh","year":"2012","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.biopha.2024.117010_bib74","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2337\/db11-0440","article-title":"Specific control of pancreatic endocrine \u03b2- and \u03b4-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9","volume":"60","author":"Lenoir","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib75","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00125-016-4113-2","article-title":"HDAC7 is overexpressed in human diabetic islets and impairs insulin secretion in rat islets and clonal beta cells","volume":"60","author":"Daneshpajooh","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib76","first-page":"2316","article-title":"Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1","volume":"118","author":"Park","year":"2008","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2024.117010_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2019.00187","article-title":"Sirtuins and Type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function","volume":"10","author":"Kitada","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molmet.2016.11.007","article-title":"Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion","volume":"6","author":"Remsberg","year":"2017","journal-title":"Mol. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib79","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00592-018-1201-4","article-title":"MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues \u03b2-cell dysfunction caused by Hdac7 upregulation","volume":"55","author":"Daneshpajooh","year":"2018","journal-title":"Acta Diabetol."},{"issue":"9","key":"10.1016\/j.biopha.2024.117010_bib80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2012.07.004","article-title":"Mitochondrial sirtuins: regulators of protein acylation and metabolism","volume":"23","author":"He","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"5-6","key":"10.1016\/j.biopha.2024.117010_bib81","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2119\/molmed.2011.00021","article-title":"Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus","volume":"17","author":"Christensen","year":"2011","journal-title":"Mol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.mpa.0000250136.72273.d7","article-title":"Pdx-1 modulates histone H4 acetylation and insulin gene expression in terminally differentiated alpha-TC-1 cells","volume":"34","author":"Wang","year":"2007","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib83","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/dna.2011.1336","article-title":"Regulation of insulin gene transcription by multiple histone acetyltransferases","volume":"31","author":"Sampley","year":"2012","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib84","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19382014.2019.1617621","article-title":"Class IIa HDACs do not influence beta-cell function under normal or high glucose conditions","volume":"11","author":"McCann","year":"2019","journal-title":"Islets"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.05.009","article-title":"Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1","volume":"1730","author":"Aramata","year":"2005","journal-title":"Biochim Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"19","key":"10.1016\/j.biopha.2024.117010_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194748","article-title":"Proposed tandem effect of physical activity and Sirtuin 1 and 3 activation in regulating glucose homeostasis","volume":"20","author":"Pacifici","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117010_bib88","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fendo.2018.00724","article-title":"Distinctive roles of sirtuins on diabetes, protective or detrimental?","volume":"9","author":"Song","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2024.117010_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2018.06.025","article-title":"Programming and regulation of metabolic homeostasis by HDAC11","volume":"33","author":"Sun","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2024.117010_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118073","article-title":"Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation","volume":"257","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"issue":"16","key":"10.1016\/j.biopha.2024.117010_bib91","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.7150\/thno.44459","article-title":"Protein acetylation derepresses Serotonin Synthesis to potentiate pancreatic beta-cell function through HDAC1-PKA-Tph1 signaling","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib92","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10741-015-9515-6","article-title":"Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes","volume":"21","author":"Patel","year":"2016","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.biopha.2024.117010_bib94","article-title":"A new era of epigenetic drug. In nutritional and therapeutic interventions for diabetes and metabolic syndrome","author":"Sch\u00fctz","year":"2018","journal-title":"MA, USA: Camb."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib95","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gene.2013.09.123","article-title":"Three single nucleotide variants of the HDAC gene are associated with type 2 diabetes mellitus in a Chinese population: a community-based case-control study","volume":"533","author":"Zeng","year":"2014","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib96","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/db07-0843","article-title":"AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5","volume":"57","author":"McGee","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib97","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/epi.14.10","article-title":"Personalized medicine and type 2 diabetes: lesson from epigenetics","volume":"6","author":"Raciti","year":"2014","journal-title":"Epigenomics"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-14-0066","article-title":"Inhibition of HDAC3 promotes ligand-independent PPAR\u03b3 activation by protein acetylation","volume":"53","author":"Jiang","year":"2014","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib99","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1440-1681.2009.05311.x","article-title":"Histone modifications and skeletal muscle metabolic gene expression","volume":"37","author":"McGee","year":"2010","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.biopha.2024.117010_bib100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diabres.2018.01.012","article-title":"Functional genetic variants within the SIRT2 gene promoter in type 2 diabetes mellitus","volume":"137","author":"Liu","year":"2018","journal-title":"Diabetes Res Clin. Pr."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib101","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10157-011-0418-0","article-title":"Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes","volume":"15","author":"Maeda","year":"2011","journal-title":"Clin. Exp. Nephrol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208634","article-title":"SIRT2 knockout exacerbates insulin resistance in high fat-fed mice[J]","volume":"13","author":"Lantier","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib103","article-title":"Sirt1 activator induces proangiogenic genes in preadipocytes to rescue insulin resistance in diet-induced obese mice","volume":"8","author":"Nawaz","year":"2018","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.biopha.2024.117010_bib104","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.1111308108","article-title":"Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production","volume":"108","author":"Jing","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"15","key":"10.1016\/j.biopha.2024.117010_bib105","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1042\/CS20170064","article-title":"Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway","volume":"131","author":"Xu","year":"2017","journal-title":"Clin. Sci. (Lond. )"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10020-022-00507-3","article-title":"H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes","volume":"28","author":"Kumar","year":"2022","journal-title":"Mol. Med"},{"key":"10.1016\/j.biopha.2024.117010_bib107","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.etap.2018.09.002","article-title":"Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress","volume":"64","author":"Hu","year":"2018","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.biopha.2024.117010_bib108","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mce.2016.09.006","article-title":"The histone deacetylase inhibitor sodium butyrate improves insulin signalling in palmitate-induced insulin resistance in L6 rat muscle cells through epigenetically-mediated up-regulation of Irs1","volume":"439","author":"Chriett","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib109","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ijo.2016.191","article-title":"Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases","volume":"41","author":"Ferrari","year":"2017","journal-title":"Int J. Obes. (Lond. )"},{"issue":"10","key":"10.1016\/j.biopha.2024.117010_bib110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrendo.2017.80","article-title":"Regulation of hepatic glucose metabolism in health and disease","volume":"13","author":"Petersen","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib111","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2010.11.086","article-title":"The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver","volume":"404","author":"Oiso","year":"2011","journal-title":"Biochem Biophys. Res Commun."},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib112","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"Mihaylova","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117010_bib113","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fendo.2020.00598","article-title":"Liver-specific knockdown of class IIa HDACs has limited efficacy on glucose metabolism but entails severe organ side effects in mice","volume":"11","author":"Ziegler","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib114","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2012.09.030","article-title":"The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis","volume":"48","author":"Dominy","year":"2012","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/db11-0313","article-title":"Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis","volume":"61","author":"Winkler","year":"2012","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.biopha.2024.117010_bib116","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1080\/10408398.2017.1350136","article-title":"Nutritional biomarkers: current view and future perspectives","volume":"58","author":"Pande","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib117","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrendo.2009.101","article-title":"SIRT1 and insulin resistance","volume":"5","author":"Liang","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7029","key":"10.1016\/j.biopha.2024.117010_bib118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.biopha.2024.117010_bib119","doi-asserted-by":"crossref","first-page":"20589","DOI":"10.1074\/jbc.M412357200","article-title":"Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes","volume":"280","author":"Frescas","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41467-017-02537-6","article-title":"Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein","volume":"9","author":"Watanabe","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib121","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.2337\/db15-0197","article-title":"The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis C virus infection","volume":"64","author":"Chen","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib122","first-page":"1677","article-title":"Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes","volume":"17","author":"Ji","year":"2019","journal-title":"Exp. Ther. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib123","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib124","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib125","article-title":"New WHO statistics highlight increases in blood pressure and diabetes, other noncommunicable risk factors","volume":"20","year":"2012","journal-title":"Cent. Eur. J. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib126","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3904\/kjim.2016.208","article-title":"Diabetic cardiomyopathy: where we are and where we are going","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J. Intern Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib127","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib128","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yjmcc.2010.11.009","article-title":"Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart","volume":"51","author":"McKinsey","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2024.117010_bib129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2024.117010_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155532","article-title":"The role of histone deacetylases in cardiac energy metabolism in heart diseases","volume":"142","author":"Yu","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2024.117010_bib131","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","article-title":"Histone deacetylases in cardiovascular and metabolic diseases","volume":"130","author":"Bagchi","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2024.117010_bib132","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2019.02.013","article-title":"HDAC inhibition as a therapeutic strategy in myocardial ischemia\/reperfusion injury","volume":"129","author":"Xie","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib133","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2018.04.090","article-title":"HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury","volume":"503","author":"Fan","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"11","key":"10.1016\/j.biopha.2024.117010_bib134","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J. Clin. Invest"},{"issue":"38","key":"10.1016\/j.biopha.2024.117010_bib135","doi-asserted-by":"crossref","first-page":"33301","DOI":"10.1074\/jbc.M111.277707","article-title":"Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle","volume":"286","author":"Sun","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117010_bib136","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4602715","article-title":"SIRT1 Activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice","volume":"2017","author":"Ma","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib137","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/cvr\/cvad102","article-title":"Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress","volume":"119","author":"Yang","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib138","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018913","article-title":"Sirtuin 3 alleviates diabetic cardiomyopathy by regulating TIGAR and cardiomyocyte metabolism","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.biopha.2024.117010_bib139","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301012R","article-title":"SIRT6: A potential therapeutic target for diabetic cardiomyopathy","volume":"37","author":"Wu","year":"2023","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.biopha.2024.117010_bib140","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun","volume":"18","author":"Sundaresan","year":"2012","journal-title":"Nat. Med"},{"issue":"Pt B)","key":"10.1016\/j.biopha.2024.117010_bib141","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.117010_bib142","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes. Metab."},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2024.117010_bib143","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2013.11.001","article-title":"US renal data system 2013 annual data report","volume":"63","author":"Collins","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib144","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00441-017-2588-x","article-title":"Epigenetics of kidney disease","volume":"369","author":"Wanner","year":"2017","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00109-021-02141-8","article-title":"Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases","volume":"100","author":"Zhang","year":"2022","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2024.117010_bib146","article-title":"Mini-review: GSDME-mediated pyroptosis in diabetic nephropathy","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.117010_bib147","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7242384","article-title":"Role of epigenetic histone modifications in diabetic kidney disease involving renal fibrosis","volume":"2017","author":"Sun","year":"2017","journal-title":"J. Diabetes Res"},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib148","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00109-021-02044-8","article-title":"Epigenetic modifications of Klotho expression in kidney diseases","volume":"99","author":"Xia","year":"2021","journal-title":"J. Mol. Med (Berl. )"},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib149","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.2013.266411","article-title":"Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse","volume":"592","author":"Chen","year":"2014","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib150","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","article-title":"Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury","volume":"297","author":"Noh","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2024.117010_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107340","article-title":"Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-\u03baB\/HDAC3 signaling[J]","volume":"95","author":"Li","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117010_bib152","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.taap.2016.06.010","article-title":"Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus","volume":"306","author":"Shan","year":"2016","journal-title":"Toxicol. Appl. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2024.117010_bib153","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.2014.111","article-title":"Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy","volume":"86","author":"Wang","year":"2014","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.biopha.2024.117010_bib154","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1681\/ASN.2013050527","article-title":"MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction","volume":"25","author":"Lin","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2024.117010_bib155","article-title":"Silencing of histone deacetylase 9 expression in podocytes attenuates kidney injury in diabetic nephropathy","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib156","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-019-1129-2","article-title":"Epigenetic risk profile of diabetic kidney disease in high-risk populations","volume":"19","author":"Xu","year":"2019","journal-title":"Curr. Diab Rep."},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib157","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.2337\/db13-1810","article-title":"Role of transcription factor acetylation in diabetic kidney disease","volume":"63","author":"Liu","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib158","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.kint.2017.12.008","article-title":"Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury","volume":"93","author":"Hong","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib159","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","article-title":"Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1\u03b1 axis in db\/db mice","volume":"56","author":"Kim","year":"2013","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib160","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2014121271","article-title":"G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes","volume":"27","author":"Wang","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib161","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s11357-013-9520-4","article-title":"SIRT3 overexpression antagonizes high glucose accelerated cellular senescence in human diploid fibroblasts via the SIRT3-FOXO1 signaling pathway","volume":"35","author":"Zhang","year":"2013","journal-title":"Age"},{"issue":"6","key":"10.1016\/j.biopha.2024.117010_bib162","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/met.2014.0140","article-title":"Increased SIRT3 expression and antioxidant defense under hyperglycemic conditions in HepG2 cells","volume":"13","author":"Gounden","year":"2015","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib163","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3892\/etm.2016.3938","article-title":"SIRT4 overexpression protects against diabetic nephropathy by inhibiting podocyte apoptosis","volume":"13","author":"Shi","year":"2017","journal-title":"Exp. Ther. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib164","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41467-017-00498-4","article-title":"Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2024.117010_bib165","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.ajpath.2011.01.044","article-title":"Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism","volume":"178","author":"Advani","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib166","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12272-017-0998-7","article-title":"Therapeutic effects of histone deacetylase inhibitors on kidney disease","volume":"41","author":"Chun","year":"2018","journal-title":"Arch. Pharm. Res"},{"issue":"24","key":"10.1016\/j.biopha.2024.117010_bib167","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1074\/jbc.RA118.007023","article-title":"Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation","volume":"294","author":"Das","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-16-0322","article-title":"Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC","volume":"232","author":"Dong","year":"2017","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib169","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022188","article-title":"Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis","volume":"9","author":"Cheloni","year":"2019","journal-title":"BMJ Open"},{"issue":"17","key":"10.1016\/j.biopha.2024.117010_bib170","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMra1909637","article-title":"Evaluation and care of patients with diabetic retinopathy","volume":"382","author":"Jampol","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib171","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-021-01428-x","article-title":"Retinal neurodegeneration in diabetes: an emerging concept in diabetic retinopathy","volume":"21","author":"Sachdeva","year":"2021","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.biopha.2024.117010_bib172","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib173","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12272-023-01482-x","article-title":"Dysregulation of histone deacetylases in ocular diseases","volume":"47","author":"Jun","year":"2024","journal-title":"Arch. Pharm. Res"},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9070599","article-title":"Inhibition of HDAC6 attenuates diabetes-induced retinal redox imbalance and microangiopathy","volume":"9","author":"Abouhish","year":"2020","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.biopha.2024.117010_bib175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.7150\/ijms.20962","article-title":"GLP-1 treatment improves diabetic retinopathy by alleviating autophagy through GLP-1R-ERK1\/2-HDAC6 signaling pathway","volume":"14","author":"Cai","year":"2017","journal-title":"Int J. Med Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117010_bib176","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12886-018-0951-7","article-title":"Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury","volume":"18","author":"Yuan","year":"2018","journal-title":"BMC Ophthalmol."},{"issue":"21","key":"10.1016\/j.biopha.2024.117010_bib177","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1080\/15384101.2020.1827509","article-title":"MicroRNA-34a promotes apoptosis of retinal vascular endothelial cells by targeting SIRT1 in rats with diabetic retinopathy","volume":"19","author":"Ji","year":"2020","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib178","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1007\/s00125-021-05431-5","article-title":"Fasting and fasting-mimicking treatment activate SIRT1\/LXR\u03b1 and alleviate diabetes-induced systemic and microvascular dysfunction","volume":"64","author":"Hammer","year":"2021","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.biopha.2024.117010_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194936","article-title":"Ginsenoside Rb1 attenuates high glucose-induced oxidative injury via the NAD-PARP-SIRT axis in rat retinal capillary endothelial cells","volume":"20","author":"Fan","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117010_bib180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang","year":"2016","journal-title":"Mol. Cells"},{"issue":"8","key":"10.1016\/j.biopha.2024.117010_bib181","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/jcmm.12557","article-title":"SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor \u03b21","volume":"19","author":"Mortuza","year":"2015","journal-title":"J. Cell Mol. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib182","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.bbadis.2017.04.024","article-title":"Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy","volume":"1863","author":"Mishra","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.117010_bib183","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1753-0407.12622","article-title":"Metabolic memory: evolving concepts","volume":"10","author":"Misra","year":"2018","journal-title":"J. Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2024.117010_bib184","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.106.171052","article-title":"Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee","volume":"113","author":"Sacks","year":"2006","journal-title":"Circulation"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224008941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224008941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:07:50Z","timestamp":1782173270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224008941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":184,"alternative-id":["S0753332224008941"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117010","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylases and inhibitors in diabetes mellitus and its complications","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117010"}}